Clearstead Advisors’s IGM Biosciences IGMS Stock Holding History

Clearstead Advisors’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-61	Closed	-$69	–	3164
2025 Q2	$69	Buy	+61	New	+$75	﹤0.01%	2651

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Clearstead Advisors's IGMS Position: Q3 2025 in Review

Clearstead Advisors sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 61 shares — an estimated $69 sold.

Clearstead Advisors first reported a position in IGMS in Q2 2025 and held it in 1 quarter. The position peaked at $69 in Q2 2025. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Clearstead Advisors reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Clearstead Advisors sold 61 IGM Biosciences shares in Q3 2025, an estimated $69.
Clearstead Advisors first reported a position in IGM Biosciences in Q2 2025 and held it in 1 quarter.
Clearstead Advisors's IGM Biosciences position peaked at $69 in Q2 2025.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.